Skip to content

A study to evaluate the proportion of patients developing kidney problems after major abdominal cancer surgeries

Incidence and Long term impact of postoperative Acute Kidney Injury in patients undergoing major abdominal surgery (IMPACT PO-AKI) - IMPACT POAKI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097097
Enrollment
174
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: C00-D49- Neoplasms

Interventions

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consenting patients more than 18 years of age, undergoing elective major abdominal surgeries including Liver, pancreatic, cytoreductive surgery with or without HIPEC. 2. Patients undergoing open, laparoscopic, laparoscopic-assisted, laparoscopic converted and robotic procedures.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to consent 2. Patients undergoing surgical procedures other than those mentioned above 3. Patients undergoing planned or unplanned nephrectomy 4. Patients with pre-existing renal disease (previous history of AKI according to KDIGO criteria) 5. Post kidney transplant patient 6. Patients with end stage kidney disease on dialysis. 7. Renal replacement therapy (any form of dialysis) within the 90 days preceding the operation

Design outcomes

Primary

MeasureTime frame
Incidence of PO-AKI (an acute alteration in kidney function) within 7 days in patients undergoing major abdominal surgery including, Hepatic resection, Pancreatic surgery, cytoreductive surgery with or without HIPECTimepoint: Within first 7 days after surgery

Secondary

MeasureTime frame
1. Incidence of Early PO-AKI ( AKI occurring within 48 hrs after surgery) 2. Incidence of AKD (a sustained alteration in kidney function over a 3-month period i.e. persisting after 7 days until 3 months after surgery) 3. Incidence of CKD (a sustained alteration in kidney function persisting beyond 3 months) 4. Long term impact of PO-AKI on kidney function at first follow up visit within 3 month after discharge, 6 months and 1 year with serum creatinine value 5. Identify factors associated with PO-AKI. 6. Association between PO-AKI and postoperative length of stay 7. Need for CRRT/ dialysis during hospital stay and until one year 8. Need for reduction/omission of chemotherapeutic drugs in postoperative chemotherapy due impaired renal function. Timepoint: at 48 hours, at the time of discharge (within 72 hours of discharge) and at 3, 6, 12 months

Countries

India

Contacts

Public ContactDr Gajanan Vaidya

Tata Memorial Hospital

vandanachaukar@gmail.com02241770004042

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026